MST1R and neoplasm: Mayer et al. revealed that RONΔ165 were detected three times more frequently in tumour samples (82.22%) in comparison to the alternatively spliced RON variant with exon 5/6 exclusion (potential RONΔ160 or RONΔ155) (24.40%) [61].